title: Susceptibility testing of Candida albicans isolated from oropharyngeal mucosa of HIV(+) patients to fluconazole, amphotericin B and Caspofungin. killing kinetics of caspofungin and amphotericin B against fluconazole resistant and susceptible isolates.
abstract: A clear understanding of the pharmacodynamic properties of antifungal agents is important for the adequate treatment of fungal infections like candidiasis. For certain antifungal agents, the determination of Minimal Fungicidal Concentration (MFC) and time kill curve could be clinically more relevant than the determination of the Minimal Inhibitory Concentration (MIC). In this study, MIC and MFC to fluconazole, amphotericin B and caspofungin against C. albicans isolates and the killing patterns obtained with caspofungin and amphotericin B against susceptible and resistant strains to fluconazole were determined. The results of MICs showed that all C. albicans isolates were highly susceptible to amphotericin B, but two isolates were fluconazole resistant. The comparative analysis between MIC and MFC showed that MFC of fluconazole was fourfold higher than MIC in 41.9% of the C. albicans isolates. Same values of MFC and MIC of amphotericin B and caspofungin were found for 71% of the isolates. Correlation between time kill curves and MFC of amphotericin B and caspofungin against all 4 isolates tested was observed. The caspofungin killing effect was more evident at MFC in 6 hours of incubation than at MIC in this time, suggesting dependence of concentration. The similarity of results of time-kill curve and MFC values indicate that determination of MFC is an alternative for the detection of the fungicidal activity of these drugs.
authors.affiliation: Instituto de Patologia Tropical e Saúde Pública da Universidade Federal de Goiás , Goiínia, GO , Brasil.
authors.forename: Janine
authors.initials: J
authors.lastname: de Aquino Lemos
authors.forename: Carolina Rodrigues
authors.initials: CR
authors.lastname: Costa
authors.forename: Crystiane Rodrigues
authors.initials: CR
authors.lastname: de Araújo
authors.forename: Lúcia Kioko Hasimoto E
authors.initials: LK
authors.lastname: Souza
authors.forename: Maria do Rosário Rodrigues
authors.initials: Mdo R
authors.lastname: Silva
keywords: Antifungal susceptibility; Candida albicans; Time kill curves
references.citation: BMC Infect Dis. 2006 Jan 20;6:8
references.pmid: 16423306
references.citation: J Clin Microbiol. 1998 Oct;36(10):2950-6
references.pmid: 9738049
references.citation: Mycoses. 2003 Sep;46(8):299-306
references.pmid: 12950898
references.citation: Mem Inst Oswaldo Cruz. 2004 Jun;99(4):425-31
references.pmid: 15322634
references.citation: J Clin Microbiol. 2006 Mar;44(3):760-3
references.pmid: 16517851
references.citation: Antimicrob Agents Chemother. 2004 Apr;48(4):1382-3
references.pmid: 15047549
references.citation: J Investig Dermatol Symp Proc. 2001 Dec;6(3):188-96
references.pmid: 11924826
references.citation: J Clin Microbiol. 2002 Mar;40(3):852-6
references.pmid: 11880404
references.citation: J Clin Microbiol. 2003 Dec;41(12):5729-31
references.pmid: 14662968
references.citation: Clin Microbiol Infect. 2004 Mar;10(3):187-9
references.pmid: 15008939
references.citation: J Antimicrob Chemother. 2003 Jun;51(6):1427-9
references.pmid: 12716772
references.citation: Antimicrob Agents Chemother. 2006 Aug;50(8):2829-32
references.pmid: 16870779
references.citation: Antimicrob Agents Chemother. 2004 Nov;48(11):4453-6
references.pmid: 15504881
references.citation: Antimicrob Agents Chemother. 1998 May;42(5):1207-12
references.pmid: 9593151
references.citation: Mycoses. 2005 Nov;48(6):385-90
references.pmid: 16262874
references.citation: Antimicrob Agents Chemother. 2004 Jul;48(7):2477-82
references.pmid: 15215097
references.citation: J Bras Pneumol. 2006 Sep-Oct;32(5):449-60
references.pmid: 17268750
references.citation: Antimicrob Agents Chemother. 2003 Mar;47(3):1068-71
references.pmid: 12604543
references.citation: Antimicrob Agents Chemother. 2000 Apr;44(4):1108-11
references.pmid: 10722525
references.citation: Mycoses. 2006 Nov;49(6):457-62
references.pmid: 17022761
references.citation: Mycopathologia. 2004 Jan;157(1):43-7
references.pmid: 15008344
references.citation: BMC Infect Dis. 2005 Nov 03;5:99
references.pmid: 16266438
references.citation: J Clin Microbiol. 2001 Dec;39(12):4387-9
references.pmid: 11724849
references.citation: Antimicrob Agents Chemother. 2006 Apr;50(4):1293-7
references.pmid: 16569843
references.citation: Rev Iberoam Micol. 2005 Mar;22(1):24-8
references.pmid: 15813679
references.citation: J Antimicrob Chemother. 2002 Dec;50(6):999-1002
references.pmid: 12461023
references.citation: Diagn Microbiol Infect Dis. 2003 Mar;45(3):203-6
references.pmid: 12663162
references.citation: Community Dent Oral Epidemiol. 2005 Feb;33(1):35-44
references.pmid: 15642045
references.citation: J Antimicrob Chemother. 1999 Oct;44(4):429-37
references.pmid: 10588302
references.citation: Diagn Microbiol Infect Dis. 1999 Feb;33(2):75-80
references.pmid: 10091029
references.citation: Antimicrob Agents Chemother. 1997 Nov;41(11):2326-32
references.pmid: 9371328
references.citation: Diagn Microbiol Infect Dis. 2000 Jan;36(1):13-8
references.pmid: 10744363